Skip to the page

Data / Form D filings / Intellect Neurosciences, Inc.

Intellect Neurosciences, Inc.: Form D filings

Intellect Neurosciences, Inc., a biotechnology company in New York, NY, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on May 7, 2010, reports $2.3 million sold of a $2.3 million offering to 7 investors.

Find out what Intellect Neurosciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
7 WEST 18TH STREET, New York, NY, 10011
Phone
(212) 448-9300
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2007
Revenue range
$1 - $1,000,000
Exemptions claimed
Rule 506
SEC identifier (CIK)
1337905

The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 7, 2010New notice$2,320,000$2,320,000$07Apr 23, 2010sec.gov
Sep 10, 2009New notice$800,000$450,000$350,0001Aug 3, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Elliot Mitchell MazaExecutive Officer

Other biotechnology companies in New York that filed recently

Every Form D from the week of May 3, 2010 · All recent filings in New York · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Intellect Neurosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.